Immunotherapy for non-small cell lung cancer

被引：11
|
作者：
Vafadar, Sam [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol, Tampa, FL 33612 USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2019年 / 32卷 / 09期
关键词：
non-small cell lung cancer; immunotherapy; nivolumab; pembrolizumab; atezolizumab; durvalumab; ADVERSE EVENTS; OPEN-LABEL; PEMBROLIZUMAB; NIVOLUMAB; DOCETAXEL;
D O I：
10.1097/01.JAA.0000569792.99069.e6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Immunotherapy is a new genre of treatment for patients with advanced cancer. Initially approved for use in metastatic melanoma, immunotherapy has found a significant place in treating non-small cell lung cancer (NSCLC). Clinical trials using several combinations of immunotherapy are underway to help to determine the best treatment for specific patient groups. This article reviews approved uses of immunotherapy for NSCLC, immune-related toxicities, and explores the future direction of this treatment.
引用
下载
收藏
页码：37 / 42
页数：6
相关论文
共 50 条
  • [41] Current state of immunotherapy for non-small cell lung cancer
    Malhotra, Jyoti
    Jabbour, Salma K.
    Aisner, Joseph
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (02) : 196 - 211
  • [42] Immunotherapy in oncogene addicted non-small cell lung cancer
    McLean, Luke
    Leal, Jose Luis
    Solomon, Benjamin J.
    John, Thomas
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2736 - 2751
  • [43] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
  • [44] Overcoming roadblocks of immunotherapy in non-small cell lung cancer
    Saha, Tanmoy
    Sengupta, Shiladitya
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
    Doroshow, Deborah B.
    Sanmamed, Miguel F.
    Hastings, Katherine
    Politi, Katerina
    Rimm, David L.
    Chen, Lieping
    Melero, Ignacio
    Schalper, Kurt A.
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4592 - 4602
  • [46] Non-small cell Lung Cancer: News from Immunotherapy
    Reinmuth, Niels
    Heigener, David F.
    Reck, Martin
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (05) : 331 - 336
  • [47] Immunotherapy in non-small cell lung cancer: advancements and challenges
    Zhou, Fei
    Zhou, Cai-Cun
    CHINESE MEDICAL JOURNAL, 2021, 134 (10) : 1135 - 1137
  • [48] New advances in immunotherapy for non-small cell lung cancer
    Qin, Haifeng
    Wang, Fang
    Liu, Hui
    Zeng, Zhen
    Wang, Shasha
    Pan, Xin
    Gao, Hongjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2234 - 2245
  • [49] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
  • [50] Non-small cell lung cancer: land of conquest for immunotherapy
    Munari, Enrico
    Bogina, Giuseppe
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5184 - 5185
12345